Expression of cholera toxin B subunit-lumbrokinase in edible sunflower seeds-the use of transmucosal carrier to enhance its fusion protein's effect on protection of rats and mice against thrombosis

Biotechnology Progress

Volumn 30, Issue 5, 2014, Pages 1029-1039

  Guan, Chunfeng ^a   Ji, Jing ^a   Jin, Chao ^a   Wang, Gang ^a   Li, Xiaozhou ^b   Guan, Wenzhu ^a  

^a TIANJIN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cholera toxin B subunit; Lumbrokinase; Sunflower; Thrombosis; Transmucosal carriers

Indexed keywords

AMINO ACIDS; BLOOD VESSELS; ELECTROPHORESIS; RATS; RECOMBINANT PROTEINS; TOXIC MATERIALS;

ANTI-THROMBOTIC EFFECT; CHOLERA TOXIN B SUBUNIT; DOWNSTREAM-PROCESSING; LUMBROKINASE; ORAL ADMINISTRATION; SUNFLOWER; THROMBOSIS; WESTERN-BLOT ANALYSIS;

DISEASES;

HELIANTHUS; MUS; RATTUS;

ANTITHROMBOCYTIC AGENT; CHOLERA TOXIN; FIBRINOLYTIC AGENT; GANGLIOSIDE GM1; HYBRID PROTEIN; LUMBROKINASE; PROTEINASE;

ANIMAL; BAGG ALBINO MOUSE; BLOOD CLOTTING TEST; CHEMISTRY; GENETICS; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PLANT SEED; RAT; SPRAGUE DAWLEY RAT; SUNFLOWER; THROMBOSIS; TRANSGENIC PLANT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD COAGULATION TESTS; CHOLERA TOXIN; ENDOPEPTIDASES; FIBRINOLYTIC AGENTS; G(M1) GANGLIOSIDE; HELIANTHUS; MALE; MICE; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SEEDS; THROMBOSIS;

EID: 84914175930     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1963     Document Type: Article

References (53)

1. Pan R, Zhang Z-J, He R-Q. Earthworm protease. Appl Environ Soil Sci. 2010, 2010.
2. Zhenjun S, Xianchun L, Lihui S, Chunyang S. Earthworm as a potential protein resource. Ecol Food Nutr. 1997;36:221-236.
3. Fan Q, Wu C, Li L, Fan R, Wu C, Hou Q, He R. Some features of intestinal absorption of intact fibrinolytic enzyme III-1 from Lumbricus rubellus. Biochim Biophys Acta. 2001;1526:286-292.
4. Li G, Wang KY, Li D, Wang N, Liu D. Cloning, expression and characterization of a gene from earthworm Eisenia fetida encoding a blood-clot dissolving protein. PloS One. 2012;7:e53110.
5. Hu Y, Meng X-L, Xu J-P, Lu W, Wang J. Cloning and expression of earthworm fibrinolytic enzyme PM 246 in Pichia pastoris. Protein Exp Purif. 2005;43:18-25.
6. Cooper EL, Ru B, Weng N. Earthworms: sources of antimicrobial and anticancer molecules. In: Complementary and Alternative Approaches to Biomedicine. Edited by Cooper EL and Yamaguchi N. Springer: US. 2004: 359-390.
7. Mihara H. Fibrinolytic enzyme extracted from the earthworm. Thrombosis Haemostasis 1983;50:258.
8. Wang KY, Tull L, Cooper E, Wang N, Liu D., Recombinant protein production of earthworm lumbrokinase for potential antithrombotic application. Evidence Based Complement Altern Med. 2013;2013: 783971.
9. Tang Y, Liang D, Jiang T, Zhang J, Gui L, Chang W. Crystal structure of earthworm fibrinolytic enzyme component A: revealing the structural determinants of its dual fibrinolytic activity. J Mol Biol 2002;321:57-68.
10. Wu JX, Zhao XY, Pan R, He RQ. Glycosylated trypsin-like proteases from earthworm Eisenia fetida. Int J Biol Macromol. 2007;40:399-406.
11. Mustata G, Dinh SM. Approaches to oral drug delivery for challenging molecules. Crit Rev Therap Drug Carrier Syst. 2006;23:111-135.
12. Arêas APM, Oliveira MLS, Miyaji EN, Leite LCC, Araújo Aires K, Dias WO, Ho PL. Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice. Biochem Biophy Res Commun. 2004;321:192-196.
13. Holmgren J, Harandi AM, Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev Vaccines. 2003;2:205-217.
14. McKenzie SJ, Halsey JF. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J Immunol. 1984;133:1818-1824.
15. Boyhan D, Daniell H. Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnol J. 2011;9:585-598.
16. Huy N-X, Yang M-S, Kim T-G. Expression of a cholera toxin B subunit-neutralizing epitope of the porcine epidemic diarrhea virus fusion gene in transgenic lettuce (Lactuca sativa L.). Mol Biotechnol. 2011;48:201-209.
17. Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J. 2010;8:620-637.
18. Ahmad P, Ashraf M, Younis M, Hu X, Kumar A, Akram NA, Al-Qurainy F. Role of transgenic plants in agriculture and biopharming. Biotechnol Adv. 2012;30:524-540.
19. Shinmyo A, Kato K. Molecular farming: production of drugs and vaccines in higher plants. J Antibiotics 2010;63:431-433.
20. Ma JK, Drake PM, Christou P. The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 2003;4:794-805.
21. Hunter P. A new era for plant biotechnology. EMBO Rep 2011;12:504-507.
22. Weber S, Friedt W, Landes N, Molinier J, Himber C, Rousselin P, Hahne G, Horn R. Improved Agrobacterium-mediated transformation of sunflower (Helianthus annuus L.): assessment of macerating enzymes and sonication. Plant Cell Rep. 2003;21:475-482.
23. Sadhu M. Effect of diferent auxins on growth & differentiation in callus tissue from sunflower stem pith. Indian J. Exp. Biol. 1974;12:110-111.
24. Jung SK, Lindenmuth BE, Hwang MS, Bui MQN, Falk BW, Uratsu SL, Phu ML, Dandekar AM, McDonald KA. Agrobacterium tumefaciens mediated transient expression of plant cell wall-degrading enzymes in detached sunflower leaves. Biotechnol Progr. 2014; 30:905-915.
25. Cantamutto MA, Poverene MM. Transgenic sunflower. In: Genetics, genomics and breeding of sunflower. Edited by Hu J, Seiler G and Kole C. Science Publishers, Inc: Lebanon. 2010:279-312.
26. Boehm R. Bioproduction of therapeutic proteins in the 21st century and the role of plants and plant cells as production platforms. Ann NY Acad Sci. 2007;1102:121-134.
27. Aydin C. Physical properties of almond nut and kernel. J Food Eng. 2003;60:315-320.
28. Hajdukiewicz P, Svab Z, Maliga P. The small, versatilepPZP family ofAgrobacterium binary vectors for plant transformation. Plant Mol Biol. 1994;25:989-994.
29. Murashige T, Skoog F. A revised medium for rapid growth and bio assays with tobacco tissue cultures. Physiol Plantarum 1962;15:473-497.
30. Lau OS, Sun SSM. Plant seeds as bioreactors for recombinant protein production. Biotechnol Adv. 2009;27:1015-1022.
31. Pan H, Yang C-P, Wei Z-G, Jiang J. DNA extraction of birch leaves by improved CTAB method and optimization of its ISSR system. J Forestry Res. 2006;17:298-300.
32. Chunfeng G, Xilong D, Gang W, Jing J, Chao J, Xiaozhou L. Expression of biologically active anti-thrombosis protein lumbrokinase in edible sunflower seed kernel. J Plant Biochem Biotechnol. 2013:1-9.
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
34. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
35. Chunfeng G, Xiaozhou L, Gang W, Jing J, Chao J, Josine TL. Expression of cholera toxin B-Lumbrokinase fusion protein in Pichia pastoris-the use of transmucosal carriers in the delivery of therapeutic proteins to protect rats against thrombosis. Appl Biochem Biotechnol. 2013;169:636-650.
36. Bekemeier H, Hirschelmann R, Giessler AJ. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis. Biomed Biochim Acta. 1984;43:S347-S350.
37. Kumada T, Ishihara M, Ogawa H, Abiko Y. Experimental model of venous thrombosis in rats and effect of some agents. Thromb Res. 1980;18:189-203.
38. Gresele P, Momi S, Berrettini M, Nenci GG, Schwarz HP, Semeraro N, Colucci M. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest. 1998;101:667-676.
39. Philipose S, Konya V, Sreckovic I, Marsche G, Lippe IT, Peskar BA, Heinemann A, Schuligoi R. The prostaglandin E2 peceptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation. Arterioscler Thromb Vascular Biol. 2010;30:2416-2423.
40. Veen JJ, Smith J, Kitchen S, Makris M. Normal prothrombin time in the presence of therapeutic levels of rivaroxaban. Br J Haematol. 2013;160:859-861.
41. Barrett YC, Wang Z, Knabb RM. A novel prothrombin time assay for assessing the anticoagulant activity of oral factor Xa inhibitors. Clin Appl Thromb Hemostasis. 2013;19:522-528.
42. Hapgood G, Butler J, Malan E, Chunilal S, Tran H. The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples. Thromb Haemost. 2013;110:308-315.
43. Riewald M, Ruf W. Science review: role of coagulation protease cascades in sepsis. Crit Care. 2003;7:123-129.
44. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci USA 1988;85:5879-5883.
45. Bertelli A, Bertelli AA, Galmozzi G, Giovannini L, Mian M. Thrombosis induced by endothelin (ET-1) and carrageenin in rats treated with indomethacin and propionyl carnitine. Drugs Exp Clin Res 1993;19:75-78.
46. Kod'ousek R, Jezdinsky J, Krajci D. Histological and ultrastructural changes of cardiomyocytes in experimental rats with tail thrombosis following subplantar application of carrageenin. Med Princ Pract. 2007;16:360-366.
47. Lencer WI. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin. Am J Physiol. 2001;280:G781-G786.
48. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J, Thivolet C. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA. 1997;94:4610-4614.
49. Gong Z, Jin Y, Zhang Y. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm. Vaccine. 2007;25:1444-1451.
50. Davies HM. Review article: Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J. 2010;8:845-861.
51. Hefferon K. Plant-derived pharmaceuticals for the developing world. Biotechnol J. 2013;8:1193-1202.
52. Yang L, Wakasa Y, Takaiwa F. Biopharming to increase bioactive peptides in rice seed. J AOAC Int. 2008;91:957-964.
53. Menkhaus TJ, Bai Y, Zhang C, Nikolov ZL, Glatz CE. Considerations for the recovery of recombinant proteins from plants. Biotechnol Prog. 2004;20:1001-1014.